Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Fragoso YD, Mendes MF, Arruda WO, Becker J, Brooks JB, Carvalho Mde J, Comini-Frota ER, Domingues RB, Ferreira ML, Finkelsztejn A, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Morales Rde R, Muniz A, Ruocco HH, Salgado PR, Albuquerque LB, Gama RA, Georgeto S, Lopes J, Oliveira CL, Oliveira FT, Safanelli J, Saldanha PC, Satomi M.
Fragoso YD, et al. Among authors: finkelsztejn a.
Arq Neuropsiquiatr. 2013 Oct;71(10):780-2. doi: 10.1590/0004-282X20130121.
Arq Neuropsiquiatr. 2013.
PMID: 24212514
Free article.